Beek Jeroen B Van has bought stock on 2 days since Jul 2018

Van Beek Jeroen B is a corporate insider and individual who has served as Chief Commercial Officer of AlloVir, Inc. (ALVR), a clinical-stage cell therapy company focused on developing and commercializing allogeneic, off‑the‑shelf viral‑specific T‑cell therapies.( As Chief Commercial Officer, he has been responsible for shaping AlloVir’s commercial strategy and overseeing preparation for potential product launches, including market access, commercialization planning, and partnership development.( In this role, he has also been a reporting insider in AlloVir’s SEC filings, reflecting his senior leadership position within the company.(

Van Beek’s compensation as Chief Commercial Officer at AlloVir totaled approximately $4.17 million in 2021, underscoring his status as a key executive and commercial leader within the organization.( His estimated net worth, based on equity holdings disclosed in 2026, is at least $142,343, primarily tied to his ownership of AlloVir stock acquired through his executive role.( Prior to and alongside his work at AlloVir, publicly available profiles identify him as a seasoned commercial executive with extensive experience in international management, commercial strategy, and team leadership within highly regulated and innovation‑driven industries.(

Written by Perplexity from public sources.